NDC 63739-478-04 - Docusate Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63739-478
- Requested NDC
- 63739-478-04
- Package NDCs from labels
- 63739-478-01, 63739-478-10, 63739-478-48, 63739-478-40, 63739-478-02, 63739-478-04
- Manufacturer
- McKesson Corporation | McKesson Corporation dba SKY Packaging | Contract Packaging Resources Inc.
- Effective date
- 2025-04-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drug Facts | McKesson Corporation | McKesson Corporation dba SKY Packaging | Contract Packaging Resources Inc. | 2025-04-22 | HUMAN OTC DRUG LABEL |
| Docusate Sodium - Cardinal Health | Cardinal Health | 2020-01-31 | HUMAN OTC DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63739-478-01 | 2023-03-24 | Drug Facts |
| 63739-478-02 | 2023-03-24 | Drug Facts |
| 63739-478-10 | 2023-03-24 | Drug Facts |
| 63739-478-40 | 2023-03-24 | Drug Facts |
| 63739-478-48 | 2023-03-24 | Drug Facts |
| 63739-478-01 | 2023-01-30 | Drug Facts |
| 63739-478-02 | 2023-01-30 | Drug Facts |
| 63739-478-10 | 2023-01-30 | Drug Facts |
| 63739-478-40 | 2023-01-30 | Drug Facts |
| 63739-478-48 | 2023-01-30 | Drug Facts |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63739-478-01 | EA - Each | 63739-478 | bb0a5458-5326-4332-96e8-f4c8db27a338 | 1 | 2012-07-24 |
| 63739-478-02 | EA - Each | 63739-478 | 6ce72269-cb12-4d4c-9885-bd94dc196fd0 | 1 | 2021-08-05 |
| 63739-478-04 | EA - Each | 63739-478 | 84e7a142-cef0-4627-a16d-51bf1d563241 | 1 | 2012-07-24 |
| 63739-478-10 | EA - Each | 63739-478 | 14ed252d-3611-448d-ab07-80a2542843a1 | 1 | 2012-07-24 |
| 63739-478-40 | EA - Each | 63739-478 | b49aa50c-70b4-4599-80a0-c1b904ca3f85 | 1 | 2017-11-06 |
| 63739-478-48 | EA - Each | 63739-478 | 08b4cea1-4cb9-4d01-a857-e0f08a454393 | 1 | 2017-11-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | PDC6A3C0OX |
| Stool Softener Laxative | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 306fd12b-ed60-40dc-a5be-2dc394bd29d2 | 2026-08-17 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | Morepen Bio Inc | 562d1b9a-09d8-92fc-e063-6394a90a1993 | 2026-08-14 | Warnings | F05Q2T2JA0 |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM164 DROPS | ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM | BM Private Limited | 5902770f-eb01-d099-e063-6394a90ad3eb | 2026-08-14 | Warnings | PDC6A3C0OX |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 8936f66f-10fe-44ab-a26e-dd8b05dfa997 | 2026-08-10 | Warnings | 6DC9Q167V3 |
| Stool Softener | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | f4671579-aed0-4f93-ab83-248e0d72b5b0 | 2026-08-10 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | Aldama Pharmaceuticals, Inc | 492b6d37-47cf-3a28-e063-6294a90a2a18 | 2026-08-10 | Warnings | F05Q2T2JA0 |
| Systane Pro PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 23b3515f-fbe5-4398-b2df-8b2eccdd01e2 | 2026-08-10 | Warnings | 6DC9Q167V3 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Shield Pharmaceuticals Corp | 0be906d8-3db5-4218-bbdf-f1d126007990 | 2026-08-07 | Warnings | F05Q2T2JA0 |
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Stool Softener Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 4e97dd60-96e3-4b51-b614-c62480af1919 | 2026-08-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 098d2377-0019-45fe-b995-700b1b1241c4 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| Docusate Sodium softgels 50mg (Dye Free) | DOCUSATE SODIUM | CVS Pharmacy | 273ea95f-3c9c-98e8-e063-6294a90a2135 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| Leader Lubricant Eye Drops 30ct | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | 8df69f2c-40c4-245c-e053-2a95a90a5406 | 2026-08-05 | Warnings | 6DC9Q167V3 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | cbb0edf4-1fa7-42f5-a6f7-027e3961b50a | 2026-08-05 | Warnings | F05Q2T2JA0 |
| CVS Glycerin | GLYCERIN SUPPOISITORY | CVS Pharmacy, Inc | ca6d13db-60e8-4fcc-b7b3-3eb280b8c435 | 2026-08-04 | Warnings | PDC6A3C0OX |
| Colace | DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | 7793fced-e8ee-44e2-b212-dd2a59a5f462 | 2026-08-04 | Warnings | F05Q2T2JA0 |
| Dual Action Senna Stool Softener | DOCUSATE SODIUM 50 MG, SENNOSIDES 8.6 MG | Shield Pharmaceuticals Corp | a04435df-aace-497f-a3a8-d8e8489db661 | 2026-08-03 | Warnings | F05Q2T2JA0 |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.